U.S. Department of Health & Human Services

NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Recently Added Within 6 Months Remove constraint Recently Added: Within 6 Months Subjects United States. Department of Health and Human Services. Remove constraint Subjects: United States. Department of Health and Human Services.
Number of results to display per page

Search Results

1. Data inadequacies undermine CMS's oversight of the inconsistency resolution process for the federal marketplace

nlm:nlmuid-101737746-pdf

2. CMS validated hospital inpatient quality reporting program data, but should use additional tools to identify gaming

nlm:nlmuid-101737750-pdf

4. CDC generally met its inspection goals for the federal select agent program: however, opportunities exist to strengthen oversight

nlm:nlmuid-101737763-pdf

6. Round 2 competitive bidding for CPAP/RAD: disrupted access unlikely for devices, inconclusive for supplies

nlm:nlmuid-101737773-pdf

8. OHRP generally conducted its compliance activities independently, but changes would strengthen its independence

nlm:nlmuid-101737781-pdf

9. HHS's Office of Refugee Resettlement improved coordination and outreach to promote the safety and well-being of unaccompanied alien children

nlm:nlmuid-101737785-pdf

10. Medicare program shared savings accountable care organizations have shown potential for reducing spending and improving quality

nlm:nlmuid-101737819-pdf

22. Enhancements needed in the tracking and collection of Medicare overpayments identified by ZPICS and PSCS

nlm:nlmuid-101737930-pdf

26. Medicare payments for clinical diagnostic laboratory tests in 2016: year 3 of baseline data

nlm:nlmuid-101737978-pdf

27. Excluding noncovered versions when setting payment for two Part B drugs would have resulted in lower drug costs for Medicare and its beneficiaries

nlm:nlmuid-101737981-pdf

29. Followup review: CMS's management of the quality payment program

nlm:nlmuid-101737984-pdf

30. Potential misclassifications reported by drug manufacturers may have led to $1 billion in lost Medicaid rebates

nlm:nlmuid-101737986-pdf

34. Round two competitive bidding for oxygen: continued access for vast majority of beneficiaries

nlm:nlmuid-101737992-pdf

35. Round two competitive bidding for enteral nutrition: continued access for vast majority of beneficiaries

nlm:nlmuid-101738020-pdf

36. HRSA helped health centers with elevated risks and can continue to take additional steps

nlm:nlmuid-101738030-pdf

42. CMS did not detect some inappropriate claims for durable medical equipment in nursing facilities

nlm:nlmuid-101738059-pdf

43. Opioids in Ohio Medicaid: review of extreme use and prescribing

nlm:nlmuid-101738060-pdf

47. Questionable billing for compounded topical drugs in Medicare Part D

nlm:nlmuid-101738131-pdf

48. FDA should further integrate its review of cybersecurity into the premarket review process for medical devices

nlm:nlmuid-101738136-pdf

49. Treatment planning and medication monitoring were lacking for children in foster care receiving psychotropic medication

nlm:nlmuid-101738140-pdf